Robert S. Landsman

Array ( [id] => 9909003 [patent_doc_number] => 20150064204 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-05 [patent_title] => 'GITR ANTIGEN BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/472116 [patent_app_country] => US [patent_app_date] => 2014-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 45592 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14472116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11003862 [patent_doc_number] => 20160200812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-14 [patent_title] => 'COMPOSITIONS AND METHODS FOR TARGETING CONNEXIN HEMICHANNELS' [patent_app_type] => utility [patent_app_number] => 14/912986 [patent_app_country] => US [patent_app_date] => 2014-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11778 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14912986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9901000 [patent_doc_number] => 20150056199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'TGF-BETA RECEPTOR TYPE II VARIANTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/465182 [patent_app_country] => US [patent_app_date] => 2014-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 33231 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14465182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9901021 [patent_doc_number] => 20150056221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'ANTI-PRLR ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/464297 [patent_app_country] => US [patent_app_date] => 2014-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29433 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14464297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10998565 [patent_doc_number] => 20160195513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-07 [patent_title] => 'EVALUATION METHOD AND SCREENING METHOD FOR S1P1 RECEPTOR AGONIST' [patent_app_type] => utility [patent_app_number] => 14/912827 [patent_app_country] => US [patent_app_date] => 2014-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4891 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14912827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11237486 [patent_doc_number] => 09464120 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-10-11 [patent_title] => 'Compositions for treatment of celiac disease' [patent_app_type] => utility [patent_app_number] => 14/459060 [patent_app_country] => US [patent_app_date] => 2014-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 32 [patent_no_of_words] => 33824 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14459060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10333279 [patent_doc_number] => 20150218283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-06 [patent_title] => 'Antibodies to Non-Functional Oligomeric P2X7 Receptors' [patent_app_type] => utility [patent_app_number] => 14/456898 [patent_app_country] => US [patent_app_date] => 2014-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 26299 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14456898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10940269 [patent_doc_number] => 20140343288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'SUBLINGUAL FENTANYL SPRAY' [patent_app_type] => utility [patent_app_number] => 14/448752 [patent_app_country] => US [patent_app_date] => 2014-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 29098 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14448752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10566239 [patent_doc_number] => 09289387 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-22 [patent_title] => 'Method of treating pain by administering sublingual fentanyl spray' [patent_app_type] => utility [patent_app_number] => 14/448720 [patent_app_country] => US [patent_app_date] => 2014-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 25452 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14448720 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11324945 [patent_doc_number] => 20160355557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-08 [patent_title] => 'SAXATILIN-FC FUSION PROTEIN AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/908906 [patent_app_country] => US [patent_app_date] => 2014-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9952 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14908906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10812192 [patent_doc_number] => 20160158353 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-09 [patent_title] => 'Compositions and Methods for the Treatment of Biofilm Infections' [patent_app_type] => utility [patent_app_number] => 14/908028 [patent_app_country] => US [patent_app_date] => 2014-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16334 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14908028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9838515 [patent_doc_number] => 20150030596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'BISPECIFIC CHIMERIC PROTEINS WITH DARPins' [patent_app_type] => utility [patent_app_number] => 14/444632 [patent_app_country] => US [patent_app_date] => 2014-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 21871 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14444632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9812462 [patent_doc_number] => 20150024407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'T1R Hetero-Oligomeric Taste Receptors' [patent_app_type] => utility [patent_app_number] => 14/338003 [patent_app_country] => US [patent_app_date] => 2014-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24738 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14338003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10567416 [patent_doc_number] => 09290574 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-22 [patent_title] => 'Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitor' [patent_app_type] => utility [patent_app_number] => 14/328336 [patent_app_country] => US [patent_app_date] => 2014-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11361 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14328336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10241714 [patent_doc_number] => 20150126709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-07 [patent_title] => 'TRAIL COLLECTIN FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/322830 [patent_app_country] => US [patent_app_date] => 2014-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 18039 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14322830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10642564 [patent_doc_number] => 09359420 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-07 [patent_title] => 'Single chain trail fusion polypeptides and encoding nucleic acids' [patent_app_type] => utility [patent_app_number] => 14/320261 [patent_app_country] => US [patent_app_date] => 2014-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 28 [patent_no_of_words] => 13999 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14320261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11290495 [patent_doc_number] => 20160340426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-24 [patent_title] => 'MODULATORS OF THE NAV 1.9 SODIUM CHANNEL FOR TREATING AN INFLAMMATORY SKIN DISEASE AND DIAGNOSTIC METHODS' [patent_app_type] => utility [patent_app_number] => 14/757529 [patent_app_country] => US [patent_app_date] => 2014-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10947 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14757529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13095615 [patent_doc_number] => 10067144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-04 [patent_title] => Antibodies against human sodium channel nav 1.9 [patent_app_type] => utility [patent_app_number] => 14/757490 [patent_app_country] => US [patent_app_date] => 2014-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 27 [patent_no_of_words] => 11702 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14757490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14031335 [patent_doc_number] => 10227406 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-12 [patent_title] => Cannabinoid receptor-1 (CB1) monoclonal antibodies [patent_app_type] => utility [patent_app_number] => 14/899551 [patent_app_country] => US [patent_app_date] => 2014-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 20705 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14899551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11922685 [patent_doc_number] => 09790255 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-17 [patent_title] => 'Transactivator of transcription (TAT) proteins and preparation method' [patent_app_type] => utility [patent_app_number] => 15/113013 [patent_app_country] => US [patent_app_date] => 2014-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 2232 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15113013 [rel_patent_id] =>[rel_patent_doc_number] =>)